Y470 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº ¹ÙºñÃò·¹ÀÌÆ® | Barbiturates, NEC causing adverse effects in therapeutic use |
|
Y471 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â º¥Á¶µð¾ÆÁ¦ÇÉ | Benzodiazepines causing adverse effects in therapeutic use |
|
Y472 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â Ŭ·Î¶öÀ¯µµÃ¼ | Cloral derivatives causing adverse effects in therapeutic use |
|
Y473 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ÆĶó¾Ëµ¥È÷µå | Paraldehyde causing adverse effects in therapeutic use |
|
Y474 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ºê·ÒÈÇÕ¹° | Bromine compounds causing adverse effects in therapeutic use |
|
Y475 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº È¥ÇÕ ÁøÁ¤Á¦ ¹× ÃÖ¸éÁ¦ | Mixed sedatives and hypnotics, NEC causing adverse effects in therapeutic use |
|
Y478 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ±âŸ ÁøÁ¤Á¦, ÃÖ¸éÁ¦ ¹× Ç׺ҾÈÁ¦ | Other sedatives, hypnotics and antianxiety drugs causing adverse effects in therapeutic use |
|
Y478 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ¸ÞŸÄí¾Æ·Ð | Methaqualone causing adverse effects in therapeutic use |
|
Y479 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â »ó¼¼ºÒ¸íÀÇ ÁøÁ¤Á¦, ÃÖ¸éÁ¦ ¹× Ç׺ҾÈÁ¦ | Sedatives, hypnotics and antianxiety drug, unspecified causing adverse effects in therapeutic use |
|
Y479 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ¼ö¸éÁ¦ NOS | Sleeping draught, drug and tablet NOS causing adverse effects in therapeutic use |
|
Y48 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ¸¶ÃëÁ¦ ¹× °¢Á¾ Ä¡·á¿ë °¡½º | Anesthetics and therapeutic gases causing adverse effects in therapeutic use |
|
Y480 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ÈíÀÔ¸¶ÃëÁ¦ | Inhaled anesthetics causing adverse effects in therapeutic use |
|
Y481 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ºñ°æ±¸¸¶ÃëÁ¦ | Parenteral anesthetics causing adverse effects in therapeutic use |
|
Y481 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ŸÀÌ¿À¹ÙºñÃò·¹ÀÌÆ® | Thiobarbiturate causing adverse effects in therapeutic use |
|
Y482 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ±âŸ ¹× »ó¼¼ºÒ¸íÀÇ Àü½Å¸¶ÃëÁ¦ | Other and unspecified general anesthetics causing adverse effects in therapeutic use |
|
Y483 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ±¹¼Ò¸¶ÃëÁ¦ | Local anesthetic causing adverse effects in therapeutic use |
|
Y484 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â »ó¼¼ºÒ¸íÀÇ ¸¶ÃëÁ¦ | Anesthetics, unspecified causing adverse effects in therapeutic use |
|
Y485 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â °¢Á¾ Ä¡·á¿ë°¡½º | Therapeutic gases causing adverse effects in therapeutic use |
|
Y49 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº Á¤½ÅÀÛ¿ë¾à¹° | Psychotropic drugs, NEC causing adverse effects in therapeutic use |
|
Y490 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â Æ®¸®»çÀÌŬ¸¯ ¹× Å×Æ®¶ó»çÀÌŬ¸¯ Ç׿ì¿ïÁ¦ | Tricyclic and tetracyclic antidepressants causing adverse effects in therapeutic use |
|